The two main endpoints were dystrophin expression and change in North Star Ambulatory Assessment (NSAA) score, which rates the performance of various motor abilities in ambulant children with Duchenne Muscular Dystrophy. Here, DMD is linked to Duchenne muscular dystrophy.